Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.6.1 extracted from

  • Moran, R.; Kuilenburg, A.B.; Duley, J.; Nabuurs, S.B.; Retno-Fitri, A.; Christodoulou, J.; Roelofsen, J.; Yntema, H.G.; Friedman, N.R.; van Bokhoven, H.; de Brouwer, A.P.
    Phosphoribosylpyrophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I (2012), Am. J. Med. Genet. A, 158A, 455-460.
    View publication on PubMed

Protein Variants

Protein Variants Comment Organism
V142L the mutation is associated with uric acid overproduction without gout but with developmental delay, hypotonia, hearing loss, and recurrent respiratory infections in human. The mutation affects both allosteric sites that are involved in inhibition of the enzyme and the ATP-binding site Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens P60891
-
-

Source Tissue

Source Tissue Comment Organism Textmining
erythrocyte
-
Homo sapiens
-
fibroblast
-
Homo sapiens
-

Synonyms

Synonyms Comment Organism
phosphoribosylpyrophosphate synthetase
-
Homo sapiens
PRPP synthetase
-
Homo sapiens
PRS-I
-
Homo sapiens